The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia. This significant milestone underscores Venus Remedies' commitment to making a substantial ... Dec 29
The $4.20-billion pharmaceutical market of the Philippines accounts for a significant market for Venus Remedies from the ASEAN region as the company moves ... Nov 04
In the US, gastric cancer is most frequently diagnosed in the advanced stage, with only approximately 5% of patients surviving beyond five years.... Jan 18
GSK plc announced updated data from GARNET cohort F evaluating dostarlimab in mismatch repair-deficient non-endometrial advanced solid cancers being presented today at the ... Jan 18
Inceptua will have exclusive rights to distribute and commercialize Apealea in Europe... Dec 28
Amgen today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for sotorasib, an investigational KRASG12C ... Dec 17
... Dec 16
Veru, announces the presentation of preclinical data demonstrating the efficacy of oral VERU-111 in the treatment of human-derived animal models of triple-negative ... Dec 14
Basilea announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ramucirumab in the ongoing FIDES-03 study with derazantinib in gastric ... Oct 28
Keytruda would be soon launched in Japan for the treatment of cancerous tumors... Aug 27
Responding to widespread supply chain disruptions, the World Bank is also helping countries access critically needed medical supplies by reaching out to suppliers on behalf ... Apr 03
New York City, home to more than 8 million people, had 157 deaths and some 15,000 cases of COVID-19, nearly one-third the ... Mar 26
Biocon and Mylan’s proposed biosimilar bevacizumab is expected to be the third biosimilar from the partnered portfolio for the cancer patients in the U.... Mar 12
This partnership between UTS and Aragen unites the capabilities, experience, and expertise of two leading organizations to assist the Australian biopharma and biotech industries advance ... Mar 04
Aptorum Group Limited , a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces positive data and development in ... Feb 12
Concept Medical Inc. (CMI) has been granted "Breakthrough Device Designation" from the U.S. Food and Drug Administration (FDA) for MagicTouch AVF, its Sirolimus drug-... Sep 13
This is a summary of research presented this morning at the International Association for the Study of Lung Cancer's World Conference on Lung Cancer. ... Sep 12
First-line pembrolizumab monotherapy provides durable long-term overall survival benefit compared to chemotherapy, according to data presented today by Dr. M. Reck, Lung Clinic ... Sep 10
-Advertisements-
.jpeg)
Friday, November 22, 2024
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)